CCR2 improves homing and engraftment of adipose-derived stem cells in dystrophic mice
Authors:
Open Access
- 7 January 2021
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 12 (1) , 1-15
Abstract
Background: Dystrophinopathy, a common neuromuscular disorder caused by the absence of dystrophin, currently lacks effective treatments. Systemic transplantation of adipose-derived stem cells (ADSCs) is a promising treatment approach, but its low efficacy remains a challenge. Chemokine system-mediated stem cell homing plays a critical role in systemic transplantation. Here, we investigated whether overexpression of a specific chemokine receptor could improve muscle homing and therapeutic effects of ADSC systemic transplantation in dystrophic mice. Methods: We analysed multiple microarray datasets from the Gene Expression Omnibus to identify a candidate chemokine receptor and then evaluated the protein expression of target ligands in different tissues and organs of dystrophic mice. The candidate chemokine receptor was overexpressed using the lentiviral system in mouse ADSCs, which were used for systemic transplantation into the dystrophic mice, followed by evaluation of motor function, stem cell muscle homing, dystrophin expression, and muscle pathology. Results: Chemokine-profile analysis identified C–C chemokine receptor (CCR)2 as the potential target for improving ADSC homing. We found that the levels of its ligands C–C chemokine ligand (CCL)2 and CCL7 were higher in muscles than in other tissues and organs of dystrophic mice. Additionally, CCR2 overexpression improved ADSC migration ability and maintained their multilineage-differentiation potentials. Compared with control ADSCs, transplantation of those overexpressing CCR2 displayed better muscle homing and further improved motor function, dystrophin expression, and muscle pathology in dystrophic mice. Conclusions: These results demonstrated that CCR2 improved ADSC muscle homing and therapeutic effects following systemic transplantation in dystrophic mice.Keywords
This publication has 53 references indexed in Scilit:
- The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) micePLOS ONE, 2018
- Skeletal muscle perfusion and stem cell delivery in muscle disorders using intra-femoral artery canulation in miceExperimental Cell Research, 2015
- How much dystrophin is enough: the physiological consequences of different levels of dystrophin in themdxmouseHuman Molecular Genetics, 2015
- Assessing Functional Performance in the Mdx Mouse ModelJournal of Visualized Experiments, 2014
- Stem cell therapy in ischemic strokeNeurology, 2012
- Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recoveryExperimental Cell Research, 2009
- Mesenchymal Stem Cell Homing: The Devil Is in the DetailsCell Stem Cell, 2009
- The influence of muscle type and dystrophin deficiency on murine expression profilesMammalian Genome, 2005
- Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxisNature Immunology, 2005
- Somatic reversion/suppression of the mouse mdx phenotype in vivoJournal of the Neurological Sciences, 1990